1. Home
  2. RAPT vs FRAF Comparison

RAPT vs FRAF Comparison

Compare RAPT & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • FRAF
  • Stock Information
  • Founded
  • RAPT 2015
  • FRAF 1906
  • Country
  • RAPT United States
  • FRAF United States
  • Employees
  • RAPT N/A
  • FRAF N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • FRAF Major Banks
  • Sector
  • RAPT Health Care
  • FRAF Finance
  • Exchange
  • RAPT Nasdaq
  • FRAF Nasdaq
  • Market Cap
  • RAPT 194.2M
  • FRAF 212.1M
  • IPO Year
  • RAPT 2019
  • FRAF N/A
  • Fundamental
  • Price
  • RAPT $26.62
  • FRAF $46.33
  • Analyst Decision
  • RAPT Buy
  • FRAF
  • Analyst Count
  • RAPT 6
  • FRAF 0
  • Target Price
  • RAPT $34.17
  • FRAF N/A
  • AVG Volume (30 Days)
  • RAPT 180.1K
  • FRAF 16.5K
  • Earning Date
  • RAPT 11-11-2025
  • FRAF 10-21-2025
  • Dividend Yield
  • RAPT N/A
  • FRAF 2.76%
  • EPS Growth
  • RAPT N/A
  • FRAF 5.82
  • EPS
  • RAPT N/A
  • FRAF 3.29
  • Revenue
  • RAPT N/A
  • FRAF $74,998,000.00
  • Revenue This Year
  • RAPT N/A
  • FRAF N/A
  • Revenue Next Year
  • RAPT N/A
  • FRAF N/A
  • P/E Ratio
  • RAPT N/A
  • FRAF $14.55
  • Revenue Growth
  • RAPT N/A
  • FRAF 8.15
  • 52 Week Low
  • RAPT $5.67
  • FRAF $28.01
  • 52 Week High
  • RAPT $27.74
  • FRAF $49.42
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 89.76
  • FRAF 46.86
  • Support Level
  • RAPT $18.08
  • FRAF $48.36
  • Resistance Level
  • RAPT $21.29
  • FRAF $48.60
  • Average True Range (ATR)
  • RAPT 1.91
  • FRAF 0.61
  • MACD
  • RAPT 0.91
  • FRAF -0.35
  • Stochastic Oscillator
  • RAPT 92.12
  • FRAF 0.00

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: